StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
INFOBEAN.NS$159.57-0.75%
Fair $159.57+0.0%

INFOBEAN.NS

INFOBEAN.NS

Technology / Software - ApplicationNSE

$159.57

-1.13 (-0.75%)

Fairly Valued+0.0%Fair Value $159.57Fund rank 38/100 · Data gapFallback financials|
SA 61/B
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $449.8M · quality 82.0/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 81/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

61/100

B

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · INFOBEAN.NSLocal privado en este navegador · INFOBEAN.NS
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$0

P/E

17.9x

↓

EV/EBITDA

10.9x

↓

ROE

21.0%

↑

Gross Margin

37.0%

↑

Debt/Equity

0.04

↓
52-Week Range$160
$89$258

TradingView lightweight chart

INFOBEAN.NS price, volumen y niveles de valoración

Último $149.17Periodo +797.3%
Fair value: $159.57

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+10.1%

FCF CAGR

-0.6%

FCF margin

13.8%

FCF / Net income

0.82x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $5.14B · net income $866.6M · FCF $706.7M

2023-FY → 2026-FY

Gross margin

37.0%+7.4% pts

Operating margin

17.2%+6.1% pts

Net margin

16.9%+7.5% pts

FCF margin

13.8%-4.9% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$5.14B$5.14B$3.95B$3.69B$3.85B
Net Income$866.6M$866.6M$379.7M$224.7M$359.6M
EBITDA$1.38B$1.38B$818.0M$660.6M$845.6M
EPS——3.882.293.69
Gross Margin37.0%37.0%30.7%30.1%29.6%
Operating Margin17.2%17.2%10.6%6.4%11.1%
Net Margin16.9%16.9%9.6%6.1%9.3%
Balance Sheet
Debt/Equity0.040.040.060.080.13
Current Ratio10.1410.14———
Cash Flow
Free Cash Flow$706.7M$706.7M$449.8M$416.5M$719.5M
Returns
ROE21.0%21.0%11.4%7.6%13.2%
Valuation
P/E17.9117.9118.8644.0334.44
EV/EBITDA10.8910.898.4214.7914.69
P/B3.743.742.163.354.56
Growth & Yield
Revenue Growth30.1%30.1%7.1%-4.4%—
EPS Growth——69.1%-37.7%—
Dividend Yield0.2%0.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +59.3%

Total return

+59.3%

Start / end P/E

n/dx → n/dx

EPS bridge

3.88 → n/d

Residual

+59.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.2%
Residual / FX / buybacks / cross-term+59.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.